Driving value with every treatment decision: Flatiron Assist and Hematology Oncology Associates of Central New York

Hematology Oncology Associates of Central New York adopted Flatiron Assist, an oncology-specific clinical decision support tool, in May 2020 to give physicians evidence-based treatment options at the point of care. Within 14 months, 84% of the practice's clinicians were using the platform. Within a six-month observation period, relative use of preferred regimens reached 100% for small-cell lung cancer, 96% for esophageal cancer, and 94% for pancreatic cancer. The tool also supported participation in value-based care programs, including the ASCO-COA Oncology Medical Home pilot, and gave enhanced reporting on pathway utilization and NCCN guideline adherence.

Flatiron Health is a Roche-owned company supplying EHR-derived oncology real-world data, captured at the source through its own OncoEMR software.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.